Skip to main content
. 2021 May 24;11:10761. doi: 10.1038/s41598-021-89592-8

Figure 1.

Figure 1

Flow chart summarizing types of tests conducted as part of our study, and numbers of actionable variants detected in each sub-group. 237 patients were analyzed by both cfDNA NGS and ddPCR, and of these tissue NGS data was available for 158 patients. 119 patients were analyzed by cfDNA NGS but not ddPCR; of these, 35 had tissue NGS data available.